Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 178.09% | 66.64% | 13.53% | 190.79% | -2.35% |
| Total Depreciation and Amortization | 95.00% | 10.39% | 4.94% | 77.08% | 207.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.61% | -106.69% | 91.78% | 56.76% | 20.04% |
| Change in Net Operating Assets | -115.35% | -139.52% | 64.48% | -1,028.60% | -28.83% |
| Cash from Operations | 184.16% | -8.71% | 24.53% | 161.29% | -9.97% |
| Capital Expenditure | -8.70% | -- | -- | -- | 90.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.81% | -11.30% | 33.48% | -173.57% | 1.59% |
| Cash from Investing | -72.09% | -17.74% | 33.48% | -173.63% | 5.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 255.77% | -35.00% | -- |
| Cash from Financing | 100.00% | -100.00% | 4,280.77% | -35.00% | 10.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 252.31% | -92.19% | 906.92% | -204.30% | -6.97% |